BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 28589382)

  • 1. Vitamin D receptor and progesterone receptor protein and gene expression in papillary thyroid carcinomas: associations with histological features.
    Yavropoulou MP; Panagiotou G; Topouridou K; Karayannopoulou G; Koletsa T; Zarampoukas T; Goropoulos A; Chatzaki E; Yovos JG; Pazaitou-Panayiotou K
    J Endocrinol Invest; 2017 Dec; 40(12):1327-1335. PubMed ID: 28589382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 25-hydroxyvitamin D3 1alpha-hydroxylase and vitamin D receptor expression in papillary thyroid carcinoma.
    Khadzkou K; Buchwald P; Westin G; Dralle H; Akerström G; Hellman P
    J Histochem Cytochem; 2006 Mar; 54(3):355-61. PubMed ID: 16314444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D-neutralizing CYP24A1 expression, oncogenic mutation states and histological findings of human papillary thyroid cancer.
    Balla B; Tobiás B; Kósa JP; Podani J; Horváth P; Nagy Z; Horányi J; Járay B; Székely E; Krenács L; Árvai K; Dank M; Putz Z; Szabó B; Szili B; Valkusz Z; Vasas B; Győri G; Lakatos P; Takács I
    J Endocrinol Invest; 2015 Mar; 38(3):313-21. PubMed ID: 25201000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered expression of key players in vitamin D metabolism and signaling in malignant and benign thyroid tumors.
    Clinckspoor I; Hauben E; Verlinden L; Van den Bruel A; Vanwalleghem L; Vander Poorten V; Delaere P; Mathieu C; Verstuyf A; Decallonne B
    J Histochem Cytochem; 2012 Jul; 60(7):502-11. PubMed ID: 22511602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions.
    Lopes N; Sousa B; Martins D; Gomes M; Vieira D; Veronese LA; Milanezi F; Paredes J; Costa JL; Schmitt F
    BMC Cancer; 2010 Sep; 10():483. PubMed ID: 20831823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression Analysis of Vitamin D Signaling Pathway Genes in Epileptic Patients.
    Mazdeh M; Ghafouri-Fard S; Hatami M; Eftekharian MM; Ganji M; Sayad A; Arsang-Jang S; Taheri M; Omrani MD
    J Mol Neurosci; 2018 Apr; 64(4):551-558. PubMed ID: 29549592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of Genes Related to Function and Metabolism of Vitamin D in Esophageal Adenocarcinoma.
    Singhal S; Kapoor H; Subramanian S; Agrawal DK; Mittal SK
    J Gastrointest Cancer; 2019 Dec; 50(4):867-878. PubMed ID: 30187205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A sorafenib-sparing effect in the treatment of thyroid carcinoma cells attained by co-treatment with a novel isoflavone derivative and 1,25 dihydroxyvitamin D3.
    Izkhakov E; Sharon O; Knoll E; Aizic A; Fliss DM; Kohen F; Stern N; Somjen D
    J Steroid Biochem Mol Biol; 2018 Sep; 182():81-86. PubMed ID: 29702263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 1,25 and 24,25 Vitamin D on Corneal Epithelial Proliferation, Migration and Vitamin D Metabolizing and Catabolizing Enzymes.
    Lu X; Chen Z; Mylarapu N; Watsky MA
    Sci Rep; 2017 Dec; 7(1):16951. PubMed ID: 29208972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired vitamin D activation and association with CYP24A1 haplotypes in differentiated thyroid carcinoma.
    Penna-Martinez M; Ramos-Lopez E; Stern J; Kahles H; Hinsch N; Hansmann ML; Selkinski I; Grünwald F; Vorländer C; Bechstein WO; Zeuzem S; Holzer K; Badenhoop K
    Thyroid; 2012 Jul; 22(7):709-16. PubMed ID: 22690899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3).
    Bareis P; Kállay E; Bischof MG; Bises G; Hofer H; Pötzi C; Manhardt T; Bland R; Cross HS
    Exp Cell Res; 2002 Jun; 276(2):320-7. PubMed ID: 12027461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vitamin D metabolism and signaling in human hepatocellular carcinoma and surrounding non-tumorous liver].
    Horváth E; Balla B; Kósa J; Lakatos PA; Lazáry Á; Németh D; Jozilan H; Somorácz Á; Korompay A; Gyöngyösi B; Borka K; Kiss A; Kupcsulik P; Schaff Z; Szalay F
    Orv Hetil; 2016 Nov; 157(48):1910-1918. PubMed ID: 27889974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of vitamin D receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue.
    Smolders J; Schuurman KG; van Strien ME; Melief J; Hendrickx D; Hol EM; van Eden C; Luchetti S; Huitinga I
    J Neuropathol Exp Neurol; 2013 Feb; 72(2):91-105. PubMed ID: 23334593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-451 as a prognostic marker for diagnosis and lymph node metastasis of papillary thyroid carcinoma.
    Zhang M; Wu W; Gao M; Fei Z
    Cancer Biomark; 2017 Jul; 19(4):437-445. PubMed ID: 28582849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
    Jiang XL; Zhang H; Chen YL; Peng L
    Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
    [No Abstract]   [Full Text] [Related]  

  • 16. Vitamin D receptor expression is linked to potential markers of human thyroid papillary carcinoma.
    Izkhakov E; Somjen D; Sharon O; Knoll E; Aizic A; Fliss DM; Limor R; Stern N
    J Steroid Biochem Mol Biol; 2016 May; 159():26-30. PubMed ID: 26907966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparable vitamin D3 metabolism in the endometrium of patients with recurrent spontaneous abortion and fertile controls.
    Tavakoli M; Salek-Moghaddam A; Jeddi-Tehrani M; Talebi S; Kazemi-Sefat GE; Vafaei S; Mohammadzadeh A; Sheikhhassani S; Zarnani AH
    Mol Reprod Dev; 2015 May; 82(5):356-64. PubMed ID: 25914243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased CYP24A1 expression is associated with BRAF(V600E) mutation and advanced stages in papillary thyroid carcinoma.
    Zou M; BinHumaid FS; Alzahrani AS; Baitei EY; Al-Mohanna FA; Meyer BF; Shi Y
    Clin Endocrinol (Oxf); 2014 Jul; 81(1):109-16. PubMed ID: 24382015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Estrogen and Progesterone Receptors in Papillary Thyroid Carcinoma in Korea.
    Ahn HY; Song RY; Ahn HS; Kim HS
    Cancer Res Treat; 2021 Oct; 53(4):1204-1212. PubMed ID: 33592140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MUC1 mucin gene, transcripts, and protein in adenomas and papillary carcinomas of the thyroid.
    Bièche I; Ruffet E; Zweibaum A; Vildé F; Lidereau R; Franc B
    Thyroid; 1997 Oct; 7(5):725-31. PubMed ID: 9349575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.